R&D Systems™ Recombinant Human Neuroligin 3/NLGN3 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human Neuroligin 3/NLGN3 Protein is derived from NS0. The Recombinant Human Neuroligin 3/NLGN3 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q9NZ94
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 54413
• Molecular Weight (g/mol): Observed M.W.: 87-101kDa, reducing conditions, Theoretical M.W.: 76kDa
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human Neuroligin 3/NLGN3 protein Ala39-Ser709 (Ser92Tyr),with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Gene Alias: ASPGX1, AUTSX1, Gliotactin homolog, HNL3, KIAA1480HNL3, neuroligin 3, neuroligin-3, NL3, NLGN3
• Common Name: Neuroligin 3/NLGN3
• Gene Symbol: NLGN3
• Biological Activity: Measured by its binding ability in a functional ELISA. When Recombinant Human Neuroligin 3/NLGN3 is immobilized at 2μg/mL, Biotinylated Recombinant Human Neurexin 1 beta Fc Chimera binds with a typical ED50 = 150-900ng/mL.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Expression System: Mouse myeloma cell line, NS0-derived Ala39-Ser709 (Ser92Tyr), with a C-terminal 6-His tag
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining